Return On Equity of Apellis Pharmaceuticals, Inc. from 30 Jun 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Apellis Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2018 to 30 Sep 2025.
  • Apellis Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 19%.
  • Apellis Pharmaceuticals, Inc. annual Return On Equity for 2024 was -79%, a 56% increase from 2023.
  • Apellis Pharmaceuticals, Inc. annual Return On Equity for 2023 was -179%, a 13% increase from 2022.
  • Apellis Pharmaceuticals, Inc. annual Return On Equity for 2022 was -205%, a 96% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Apellis Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 19% +123% 01 Jul 2025 30 Sep 2025
Q2 2025 -116% +23% +16% 01 Apr 2025 30 Jun 2025
Q1 2025 -100% +61% +38% 01 Jan 2025 31 Mar 2025
Q4 2024 -79% +99% +56% 01 Oct 2024 31 Dec 2024
Q3 2024 -104% +105% +50% 01 Jul 2024 30 Sep 2024
Q2 2024 -139% +74% +35% 01 Apr 2024 30 Jun 2024
Q1 2024 -161% +65% +29% 01 Jan 2024 31 Mar 2024
Q4 2023 -179% +26% +13% 01 Oct 2023 31 Dec 2023
Q3 2023 -209% -14% -7.4% 01 Jul 2023 30 Sep 2023
Q2 2023 -213% +59% +22% 01 Apr 2023 30 Jun 2023
Q1 2023 -226% +382% +63% 01 Jan 2023 31 Mar 2023
Q4 2022 -205% +5592% +96% 01 Oct 2022 31 Dec 2022
Q3 2022 -195% +3430% +95% 01 Jul 2022 30 Sep 2022
Q2 2022 -272% +563% +67% 01 Apr 2022 30 Jun 2022
Q1 2022 -607% -365% -151% 01 Jan 2022 31 Mar 2022
Q4 2021 -5797% -5625% -3268% 01 Oct 2021 31 Dec 2021
Q3 2021 -3625% -3285% -966% 01 Jul 2021 30 Sep 2021
Q2 2021 -835% -552% -195% 01 Apr 2021 30 Jun 2021
Q1 2021 -242% +44% +15% 01 Jan 2021 31 Mar 2021
Q4 2020 -172% +46% +21% 01 Oct 2020 31 Dec 2020
Q3 2020 -340% -207% -155% 01 Jul 2020 30 Sep 2020
Q2 2020 -283% -178% -170% 01 Apr 2020 30 Jun 2020
Q1 2020 -286% -209% -271% 01 Jan 2020 31 Mar 2020
Q4 2019 -219% -147% -207% 01 Oct 2019 31 Dec 2019
Q3 2019 -133% -71% -114% 01 Jul 2019 30 Sep 2019
Q2 2019 -105% -39% -60% 01 Apr 2019 30 Jun 2019
Q1 2019 -77% 01 Jan 2019 31 Mar 2019
Q4 2018 -71% 01 Oct 2018 31 Dec 2018
Q3 2018 -62% 01 Jul 2018 30 Sep 2018
Q2 2018 -65% 01 Apr 2018 30 Jun 2018

Apellis Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -79% +99% +56% 01 Jan 2024 31 Dec 2024
2023 -179% +26% +13% 01 Jan 2023 31 Dec 2023
2022 -205% +5592% +96% 01 Jan 2022 31 Dec 2022
2021 -5797% -5625% -3268% 01 Jan 2021 31 Dec 2021
2020 -172% +46% +21% 01 Jan 2020 31 Dec 2020
2019 -219% -147% -207% 01 Jan 2019 31 Dec 2019
2018 -71% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.